A collaboration has been formed between the US pharmacy chain Walgreens and the Cardiovascular Research Foundation (CRF) to measure how prevalent valvular heart disease (VHD) is among older Americans.
Complete clinical trials solution company, Hawthorne Effect, announced today (October 10) it had successfully recruited more than 1,000 patients in 48 states plus Hawaii for a study to qualify the prevalence of valvular heart disease (VHD).
Columbia University is running three separate efforts to improve diversity within clinical trials, and it released data showing that early improvements could be seen.
The organization collaborates with companies across the pharma industry to create new, free resources to help improve diversity, equity, and inclusion in digitized clinical trials.
Amgen joins the Winn Award Program that was set up by Bristol Myers Squibb, with plans to extend the reach of clinical trials into underserved patient populations in the US.
The not-for-profit organization published its fair inclusion score to measure and rank pharmaceutical companies on their inclusion of women, older adults, and racial and ethnic minoritized patients.
A $114m diversity in clinical trials initiative supported by the Bristol Myers Squibb Foundation (BMSF) and Gilead Sciences has selected 64 physicians for awards.
A leader suggests considering patient views and needs all along the clinical development path reaps a number of benefits, including time and cost savings.
A survey by SubjectWell indicates that having Spanish-speaking research personnel increases interest in trial participation among Latino potential patients.
The research institutions are joining on a community-based collaborative initiative to work toward greater study inclusion, supported by funding from PhRMA.
The latest indepth report from the AI-centric analytics provider reveals nearly half of US cancer clinical studies enroll no Latino patient participants.
The pharmaceutical company is expanding its alliance with historically Black medical schools to bolster the battle against systemic health disparities.
The sponsorship from Janssen Pharmaceutical Companies will be used by the cancer support network to boost diversity in Phase I and Phase 2 clinical trials.
Parexel's Community Alliance Network, designed to more deeply integrate clinical research into community healthcare, has invited Javara and CVS as members
Unveiled at the 2022 BIO International Convention, the group's third annual diversity, equity, and inclusion report spotlights improvements both made and needed.
A Touch, the Black Breast Cancer Alliance leader discusses how a grant from Genentech is helping the organization break down barriers in care and research.
Through its Health Equity and Diversity in STEM Innovation Fund, the biotech is looking to increase equity in care and diversify the scientific workforce.
The DATAcc has released a collection of open-access resources that are intended to help users build inclusivity into digital health measurement products.
The clinical trial tech firm has announced a $220m Series D funding round which will boost its efforts to improve inclusivity and representation in studies.
The pharmaceutical firm and university have launched T-REX, a multi-year partnership focused on increasing health outcomes for underrepresented populations.
The US agency’s latest draft document lays out guidelines to help increase involvement of underrepresented ethnic and racial populations in clinical research.
A recent online event hosted by the patient services company invited a number of women to share their experience and insights working in the research field.
A leader from the patient recruitment specialist discusses the industry’s ongoing challenges with patient population diversity, and potential solutions.
A leader from the trial platform company discusses how patient experience can be enhanced when the clinical trial team shares a background with the subjects.
The pharmaceutical company has announced 24 grants totaling nearly $8m USD to fuel training and support for community health workers and patient navigators.
With two decades of experience as a practicing psychiatrist, mdgroup medical director Arthur Lazarus offers broad experience and strong patient advocacy.
The latest in the Diversity in Oncology series, taking place February 9, will discuss ways academia and community collaboration can narrow representation gaps.
The collaboration between the trial tech company and heathcare firm is aimed at increasing study access at MinuteClinic locations using Medable’s software.
On World Cancer Day, the Union for International Cancer Control is launching a three-year campaign with the goal to improve cancer care around the globe.
The organization is working to give oncology professionals the chance to hear directly from patients about their unique experiences, concerns, and hopes.
According to an expert from the clinical insights company, prejudice in AI can impact patient outcomes as well as the ability to develop effective treatments.
The healthcare company has gifted $1m to form a scholarship fund for students headed toward careers in clinical research, with the aim of increasing diversity.
The organizations have issued an in-depth look on issues impacting inclusivity, why change is needed, and potential solutions for increasing trial diversity.
An expert from the decentralized clinical trial solutions provider discusses how the virtual format and technology can help improve study representation.
Patient data from the clinical solutions company indicates that gains in recruitment of Black participants is outpacing that of patients from other groups.
An expert from the decentralized study solutions company shares perspectives on the importance of inclusivity and solutions that could improve representation.
The conference (with online and in-person content) is slated to gather professionals for deep conversations and lively collaboration on important topics.
A leader from the division of Eli Lilly explains the importance of driving greater trial inclusivity, and why collaboration is vital in making progress.
The pharmaceutical firm has tapped the decentralized research organization in order to help elevate the inclusivity of its oncology trials at all levels.
A leader from Longboat by Advarra outlines what it really means for a study to be patient centric, and how to succeed in achieving patient-centric trials.
Elligo Health Research is joining forces with Laguna Clinical Research Associates to expand access to clinical care to a broader range of patient populations.
The company’s Patient Advisory Council brings together a range of people and perspectives to help ensure increased diversity, inclusivity and engagement.
William Gholston, with the Tampa Bay Buccaneers football team, is donating to the Moffitt Cancer Center to fund research into cancer treatment disparities.
A real-world evidence generation expert discusses how clinical trial teams can make use of RWE to help improve diversity and inclusivity in their studies.
The clear evidence of increased risk of COVID-19 infection amongst ethnic minority groups, people from Black and Asian backgrounds, is of urgent public health importance, according to the authors of a paper published today by The Lancet.
